Arkolith/Insider Trading/CRSP/Form 4

Kulkarni Samarth

Chief Executive Officer, DirectorCRISPR Therapeutics AG (CRSP) · full profile →Form 4 · filed Aug 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$761K
Net Open-Market Flow
-$761K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2025Sell(S)13K$58.15$761K207K
Aug 16, 2025Option exercise(M)25K——220K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 16, 2025Option exercise(M)25K——0

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001682019-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML